Pharmacists' views on the impact of the Falsified Medicines Directive on community pharmacies: A cross-sectional survey [PDF]
Exploratory Research in Clinical and Social Pharmacy, 2022 Background: The Falsified Medicines Directive (FMD) was implemented to minimise the circulation of falsified medicines in the legal pharmaceutical supply chain.
Kevin D Murphy, Kieran Dalton
exaly +9 more sources
Falsified Medicines Directive in a Secondary Care Environment—Impact on Supply Chain [PDF]
International Journal of Environmental Research and Public Health, 2022 The Falsified Medicines Directive (FMD) and the Delegated Regulation (DR) impact the pharmaceutical supply chain. Ahead of the deadline for implementation, in February 2019, every entity of the supply chain had to adapt its operations to the regulatory requirements to be compliant with the directive.
Katarzyna Plagens-Rotman +2 more
exaly +7 more sources
Falsified Medicines Directive: Are We Heading in the Right Direction? [PDF]
Medicine Access Point of Care, 2017 Falsified medicines for human use are an increasing problem in Europe. The Falsified Medicines Directive (FMD) 2011/62/EU provides measures to prevent the entry of falsified medicines into the legal supply chain by requiring the placing of safety ...
Roberto Frontini
exaly +5 more sources
The EU Falsified Medicines Directive: Key Implications for Dispensers [PDF]
Medicine Access Point of Care, 2017 The EU Falsified Medicines Directive (FMD) mandates the serialisation of prescription-only medicines using a two-dimensional (2D) barcode by pharmaceutical companies and the systematic verification of this 2D barcode in pharmacies.
Bernard Naughton
exaly +6 more sources
Pilot Implementation of Falsified Medicines Directive in Hospital Pharmacy to Develop Best Practices for Medicine Decommissioning Process [PDF]
Pharmacy (Basel, Switzerland), 2020 Background: The introduction of a medicines verification and decommissioning system into the hospital pharmacy may result in an increased workload for pharmacy staff.
Piotr Merks +2 more
exaly +7 more sources
Evaluation of community pharmacists’ readiness to implement the Falsified Medicines Directive (Directive 2011/62/EC): an English cross-sectional survey with geospatial analysis [PDF]
BMJ Open, 2020 Objectives To evaluate the readiness to implement the Falsified Medicines Directive (FMD) by community pharmacies in England. Eight secondary objectives were assessed.Setting Community/retail pharmacies.Participants We invited pharmacists from 501 ...
Ravina Barrett
exaly +6 more sources
Hospital Audit as a Useful Tool in the Process of Introducing Falsified Medicines Directive (FMD) into Hospital Pharmacy Settings—A Pilot Study [PDF]
Pharmacy (Basel, Switzerland), 2017 Background: Recently, the European Union has introduced the Falsified Medicines Directive (FMD). Additionally, in early 2016, a Delegated Act (DA) related to the FMD was published.
Piotr Merks +2 more
exaly +8 more sources
Survey of workflow and cost implications of decommissioning regarding the Falsified Medicines Directive in Hungarian hospital pharmacies [PDF]
BMJ Open, 2021 Objectives, setting and participants In July 2011, the EU adopted the Falsified Medicines Directive (FMD) primarily aiming to prevent the infiltration of falsified medicines into the legitimate supply chain.
Antal Zemplényi +8 more
doaj +5 more sources
Falsified Medicines Directive news: EDQM announce collaboration with the European Medicines Verification Organisation [PDF]
European Journal of Hospital Pharmacy, 2016 The European Directorate for the Quality of Medicines & HealthCare (EDQM), an agency of the Council of Europe, has announced a new relationship with the European Medicines Verification Organisation (EMVO). EDQM will in future conduct periodic conformity assessments of the European Medicines Verification System (EMVS) and its governance.
Price R.
exaly +5 more sources
The impact of global falsified medicines regulation on healthcare stakeholders in the legitimate pharmaceutical supply chain: a systematic review [PDF]
Frontiers in MedicineBackgroundFalsified medicines and their international regulation impacts all healthcare sectors and their actors. These regulations aim to strengthen and protect the global pharmaceutical supply chain against falsified medicines.
Bernard Naughton
exaly +4 more sources